Search

everythinglearnresearchcommunity

for

Search:↓

The MXD/24HA salt is more effective for hair growth than raw MXD.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Using both minoxidil and finasteride together is more effective for male hair loss than using either one alone.

Rapamycin reduces age-related hearing cell loss in mice, but acarbose does not.

Some antiseizure medications can cause cosmetic problems like hair loss, excessive hair growth, acne, and gum overgrowth.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

About 43% of people in Europe have had a skin condition in the past year, with fungal infections, acne, and eczema being the most common.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Elephant tail-hair can show past stress levels, matching times when stressful events happened.

The study found that Tourette Syndrome may be linked to certain immune system processes and synaptic signaling.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

The Virtual Magic Wand program successfully trained dermatologists in innovation, with most feeling capable of leading innovation teams and many starting companies.

The FDA rejected a testosterone drug again due to safety concerns.

The FDA did not approve a testosterone drug because of safety concerns.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Chitosan-decorated nanoparticles can improve skin delivery and reduce side effects of finasteride.

Off-label drug use can be risky but sometimes beneficial when standard treatments fail.